GMGabriela Martínez-Díaz

Gabriela Martínez-Díaz

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Gabriela Martínez-Díaz has a total of 24 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Clear cell meningioma: Experience at a medical center

    by Jorge Luis Olivares Peña, Hector Ricardo Lara Torres, Jorge Luis Olivares Camacho, Jorge Arturo Santos Franco, María del Pilar Cruz Dominguez, Fiacro Jimenez-Ponce, Gabriela Martínez Díaz, Jesús Ricardo Cazadero Márquez

    Background: Clear cell meningiomas (CCMs) are a rare variant, represent approximately 1% of all craniospinal meningiomas reported worldwide, and typically appear in young and adult individuals, more frequently in women. Although they are classified by the World Health Organization as grade 2, they are meningiomas that often behave aggressively and have a high recurrence rate. Case Description: 337 records of patients with a histopathological diagnosis of intracranial meningiomas were retrospectively analyzed between January 2017 and December 2022. Three CCM cases are presented as examples. From the 337 records analyzed, 10 were CCM-related (2.96%). This paper describes three cases of meningiomas operated on at La Raza National Medical Center Specialty Hospital (HECMNR) (HECMNR, in Spanish), which belongs to the Mexican Institute of Social Security. The first case was operated with a Simpson grade I resection of the lesion and then developed other two recurrence events, which required another two interventions with Simpson II and III resections, respectively, despite oncological therapy. The second instance utilized a Simpson III resection and was promptly subjected to radiotherapy and currently developed tumoral recurrence that will soon require resection. The third case used a Simpson V resection, since the severe cerebral edema prevented a higher degree of resection. Conclusion: CCMs have a high risk of recurrence, making reintervention necessary, and therefore, cranial deformity and severe functional and neurological complications may follow, which explains the difficulty in managing this pathology.

  • In-hospital mortality and associated factors in patients with systemic lupus erythematosus: analysis over more than 11 years in a reference hospital center

    by Michelle Arrucha-Cozaya, Nuria Cecilia Zamora-Zúñiga, Dafhne Miranda-Hernández, Reyna Bustamante-González, Gabriela Martínez-Díaz, Drusila Tovar-Rodríguez, Berenice López-Zamora, María Del Pilar Cruz-Domínguez, Abraham Edgar Gracia-Ramos, Miguel Angel Saavedra

    Systemic lupus erythematosus (SLE) is a disease that affects the immune system, and it can lead to increased morbidity and mortality. The primary causes of mortality for individuals with SLE are disease activity, infections, drug toxicity, and other health conditions. The aim of this study is to estimate the mortality rate of patients with SLE who are hospitalized, describe the causes of death, and identify factors associated with mortality. The study was conducted at a referral hospital from 2009 to 2021, utilizing a nested case–control design. The records of patients with SLE who were hospitalized in the Department of Rheumatology were reviewed. Cases were identified as individuals who died during their hospitalization, while controls were those who were discharged alive during the same period. Elective hospitalizations were not included in the study. The primary causes of death were recorded, and demographic, clinical, laboratory, and immunological variables were analyzed as potential risk factors associated with in-hospital mortality. The study included 105 patients who died while hospitalized and 336 who were discharged alive. The estimated mortality rate was 10.93 deaths per 1000 hospital admissions per year. The leading causes of death were SLE activity (20%), infections (34.2%), or a combination of both (24.8%). Risk factors associated with in-hospital mortality were any infection (OR 2.5, CI 95% 1.2–5.2), nosocomial infections (OR 5.0, CI 95% 1.8–13.7), SLEDAI-2K > 2 (OR 2.0, CI 95% 1.02–3.8), lymphopenia (OR 2.1, CI 95% 1.01–4.6), anemia (OR 2.9, CI 95% 1.4–5.7), and thrombocytopenia (OR 3.3, CI 95% 1.7–6.4). Disease activity and infections, particularly nosocomial infections, are significant causes of mortality in hospitalized patients with SLE. Furthermore, hematological manifestations play a significant role in in-hospital mortality for these patients.


  • Influence of visceral adiposity on cardiovascular risk in patients with systemic sclerosis

    by Gabriela Martínez-Díaz, María Pilar Cruz-Domínguez, Berenice López Zamora, Jordan Ramirez-Facio, Gabriela Medina, Ricardo Xavier Munguía-Cruz, Miguel Angel Saavedra-Salinas, Michelle Arrucha-Cozaya, Olga Lidia Vera-Lastra, Ana Lilia Peralta-Amaro, et al.

    Systemic sclerosis (SSc) is an autoimmune disease characterized by systemic inflammation, endothelial dysfunction, generalized fibrosis and high cardiovascular mortality. The evaluation of cardiovascular risk through the visceral adiposity index (VAI) has been helpful due to its direct relationship to the body and visceral fat percentage. We evaluated the influence of body composition and anthropometrics on cardiovascular risk as measured by VAI in healthy controls (HC) and SSc. An analytical cross-sectional study of 66 participants (33 SSc and 33 HC), mean age 52.7 ± 10, 95% women, was conducted from August 2020 to January 2021. Inclusion criteria in cases were consecutive patients with SSc (ACR/EULAR 2013), 63.6% were diffuse cutaneous (dcSS) subtype, and 36.4 were limited cutaneous (lcSS) subtype. HC was matched by age and gender. Serum lipid profiles and InBody anthropometrics were analyzed and compared. We performed descriptive statistics, bivariate analysis with Student’s t, or Mann–Whitney U, correlation and chi-square according to the variable type and distribution. Total cholesterol was significantly higher in SSc than HC (345 vs 194, p = < 0.001). The BMI was higher in HC (26.2 vs 28.9, p < 0.001). Kilograms of muscle (19.8 vs 28.9, p < 0.001) and total fat (23.4 vs 28.9, p < 0.001) were lower in SSc patients compared to HC. VAI was similar when BMI < 25, but significantly higher when BMI > 25 in SSc than in HC (3 vs 1.9, p = 0.030). The increase in BMI at overweight or obese in SSc is associated with a significant increase in cardiovascular risk.


  • Open Access

    Incidencia de enfermedad crónica avanzada, necesidad de cuidados paliativos y mortalidad intrahospitalaria

    by José Luis Canizal-Oñate, Drusila Tovar-Rodríguez, Norma León-Armas, Gabriela Martínez-Díaz, Berenice López-Zamora, María del Pilar Cruz-Domínguez, Michelle Arrucha-Cozaya, Olga Lidia Vera-Lastra, Gabriela Medina-García

    Existe un continuo aumento en la prevalencia de personas afectadas con enfermedades crónicas progresivas. Los cuidados paliativos constituyen otra forma de atención y organización de problemas de salud que mejoran la calidad de vida. determinar la incidencia de pacientes con enfermedades crónicas avanzadas y necesidad de cuidados paliativos (ECAP) y la mortalidad intrahospitalaria en un hospital de tercer nivel. estudio observacional prospectivo en pacientes hospitalizados mayores de 18 años en el servicio de Medicina Interna cumpliendo al menos un criterio de la herramienta NECPAL CCOMS-ICO, siguiéndose hasta su fallecimiento o egreso para determinar mortalidad intrahospitalaria. Se utilizó estadística descriptiva e inferencial. se estudiaron 370 ingresos de abril a agosto 2021, de ellos se incluyeron 110 pacientes, 59 mujeres (55.3%) y 51 hombres (44.7%), edad 65.5 ± 15.85 años. Se determinó una incidencia de ECAP de 29.7%. La comorbilidad más frecuente fue la oncológica en 39 pacientes (35.5%); seguida de enfermedad cardiaca crónica en 17 pacientes (15.5%), 38 pacientes se catalogaron grado NECPAL I (34.5%), 44 NECPAL II (40%) y 28 NECPAL III (25.5%). Fallecieron 25 pacientes durante su estancia intrahospitalaria, con una mortalidad del 22.7%. la incidencia de pacientes hospitalizados con necesidad de cuidados paliativos es considerable, siendo en más de la mitad de ellos por patología no oncológica. Se requiere contar con estrategias de atención más eficaces para referencia externa y cuidados intrahospitalarios multidisciplinarios.